Denali Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $553.2M
Liabilities Breakdown FY2019
Total Liabilities: $158.3M
Asset Breakdown
Total Assets: $553.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $79.4M | 14.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $46.7M | 8.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $427.1M | 77.2% |
Liabilities Breakdown
Total Liabilities: $158.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 1.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $155.8M | 98.4% |